Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 0.06 (3.33%) Market Cap: 506.90 Mil Enterprise Value: 908.43 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 62/100

Q4 2020 Pacific Biosciences of California Inc Earnings Call Transcript

Feb 10, 2021 / 09:30PM GMT
Release Date Price: $45.9 (+16.08%)
Operator

Thank you for standing by, and welcome to the Pacific Biosciences of California, Inc. Fourth Quarter 2020 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to Trevin Rard. Please go ahead.

Trevin Rard
Pacific Biosciences of California, Inc. - Head of IR

Thank you. Good afternoon, and welcome to the Pacific Biosciences Fourth Quarter 2020 Earnings Conference Call. We hope that you're keeping well during this time. Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or alternatively, as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Christian Henry, President and Chief Executive Officer; Susan Kim, Chief Financial Officer; Mark Van Oene, Chief Operating Officer; and Ben

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot